BSEBoard Meeting2d ago · 17 Aug 2026, 04:06 pm
The Board of Directors of the Company at its meeting held on Monday, August 17, 2026, at the Registered Office, inter alia, considered and approved: 1. Director's Report, Secretarial Audit ....
Vivanza Biosciences Ltd · 530057
✦ AI SummaryResults
Vivanza Biosciences Ltd held its Board Meeting on August 17, 2026, and approved various business proposals, including Director's Report, Secretarial Audit Report, and related party transactions. The company also approved the adoption of a new Memorandum of Association and Articles of Association, and increased borrowing limits.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vivanza Biosciences Ltd - 530057 - Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026
Attachments (1)
📄pdf
Download →
332cd086-2fd3-4cb1-aeb0-c158f525944b.pdf
View document text
VIVANZA BIOSCIENCES LIMITED
Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054.
Phone: 07405699869, email: info@vivanzabiosciences.com, web: www.vivanzabiosciences.com
CIN: L24110GJ1982PLC005057
Date: 17.08.2026
Corporate Relationship Department,
BSE Limited
Phiroze Jeejeebhoy Tower,
Dalal Street,
Mumbai — 400001
Scrip Code: 530057 ISIN: INE984E01035
Dear Sir/Madam,
In compliance with Regulation 30 read with Part A of Schedule III of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations
2015 ("Listing Regulations"), we wish to inform you that the Board of Directors of the
Company at its meeting held today i.e., Monday, August, 17th 2026 at Registered Office of
the Company has inter alia considered and approved the following businesses:
1. The Board approved the Director's Report, Secretarial Audit Report, and all
accompanying annexures for the Financial Year 2025-26.
2. The Board approved convening of the 44th Annual General Meeting (AGM) along
with the issuance of draft Notice containing the day, date, time, and venue of the
meeting.
3. The Board appointed Mr. Chintan K. Patel, Practicing Company Secretary (Mem No:
A31987, COP: 11959), as the Scrutinizer to oversee the e-voting and poll process.
4. Fixed Friday, September 04, 2026, as the cut-off date to determine member
eligibility for attending and voting via remote e-voting or poll at the AGM
5. The Board approved the adoption of a new Memorandum of Association (MoA) and
Articles of Association (AoA) of the company, aligned with the Companies Act, 2013,
subject to shareholder approval.
6. The Board approved the proposal for seeking approval of the Members for entering
into material Related Party Transactions proposed to be undertaken by the
Company during the Financial Year 2026-27.
7. The Board approved the proposal for seeking approval of the Members under
Section 180(1)(c) of the Companies Act, 2013, for increasing the borrowing limits of
the Company beyond the aggregate of its paid-up share capital, free reserves and
securities premium, as may be applicable.
8. The Board approved the proposal for seeking approval of the Members for
undertaking such financial transactions, including loans, guarantees or securities,
involving entities/persons covered under Section 185 of the Companies Act, 2013,
subject to applicable provisions of law.
9. The Board approved the proposal for seeking approval of the Members under
Section 186 of the Companies Act, 2013, for making investments, granting loans,
VIVANZA BIOSCIENCES LIMITED
Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054.
Phone: 07405699869, email: info@vivanzabiosciences.com, web: www.vivanzabiosciences.com
CIN: L24110GJ1982PLC005057
providing guarantees or giving securities in excess of the limits prescribed under
the said Section.
The meeting of the Board of Directors of the Company commenced at 03:00 P.M. and
concluded at 03:40 P.M.
We request you to take the same on record.
Thanking You.
FOR, VIVANZA BIOSCIENCES LIMITED
JAYENDRA MEHTA
MANAGING DIRECTOR
DIN: 08210602